Canada Sexually Transmitted Disease Testing Market Insights Forecasts to 2033

• The Canada Sexually Transmitted Disease Testing Market Size was valued at USD 243.2 Million in 2023
• The Market Size is Growing at a CAGR of 3.96% from 2023 to 2033.
• The Canada Sexually Transmitted Disease Testing Market Size is Expected to Reach USD 358.6 Million by 2033.

The Canada Sexually Transmitted Disease Testing Market size is expected to reach USD 358.6 Million by 2033, at a CAGR of 3.96% during the forecast period 2023 to 2033.     

Market Overview

Sexually transmitted diseases (STDs) and infections (STIs), also referred to as sexually transmitted illnesses, are contracted through sexual activity. They are typically transferred during vaginal, oral, or anal sex. On the other hand, they can occasionally spread by several types of sexual contact with the penis, vagina, mouth, or anus. This is because some STDs, like herpes and HPV, can be spread through skin-to-skin contact. During or after giving birth, a pregnant person might transmit some sexually transmitted diseases to their unborn child. Sharing needles, receiving blood transfusions, and breastfeeding are three more ways that sexually transmitted diseases can spread. In addition, sexually transmitted infections (STIs) like chlamydia, HIV/AIDS, and HPV are becoming more common. The expansion of the Canada sexually transmitted disease testing market is anticipated to be aided by expanding government efforts aimed at raising patient knowledge of STD diagnosis and sexual health. The rising transition of patients from laboratory testing to point-of-care testing is one of the most important trends in the STD testing market. To cure the illness and stop the virus from spreading from person to person, STD diagnosis is essential. The government is putting more of an emphasis on raising awareness of STDs because of the rising frequency of the condition in the nation. Additionally, the government is working to raise the national STD diagnostic rate.

Report Coverage

This research report categorizes the market for the Canada sexually transmitted disease testing market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada sexually transmitted disease testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada sexually transmitted disease testing market.

Driving Factors

The need for sexually transmitted disease testing is anticipated to increase in tandem with the rising prevalence of STDs in Canada's population. Furthermore, it is projected that during the forecast period, the growing activities from industry participants to introduce diagnostic kits and tests will support market expansion. On the other hand, it is anticipated that the prevalence of STDs will rise in Canada due to a lack of knowledge about safer sexual practices and inappropriate sharing of infected personal items, such as used needles and other personal things. For instance, a study conducted by the condom company Trojan in collaboration with the University of Guelph, the Sex Information and Education Council of Canada (SIECCAN), and other organizations revealed that a large number of young Canadians, specifically those between the ages of 18 and 24, do not use condoms. People who fit this description are more likely to contract STDs. The country's market is predicted to grow as a result of the rising prevalence of STDs and the introduction of new products by significant industry players. In addition, data from the Public Health Agency of Canada (PHAC) indicate that Sexual and Reproductive Health Awareness Week is observed in Canada every year during the week of February 14–18. This annual campaign seeks to raise public awareness of sexual and reproductive health issues while highlighting available options to enhance community health in Canada.

Restraining Factors

A sizable portion of the patient population continues to refuse STD testing, despite numerous government-initiated campaigns to raise awareness and stop the spread of STDs in Canada. As a result, this factor has been limiting market expansion.

Market Segment

• In 2023, the reagents & kits segment accounted for the largest revenue share over the forecast period.

Based on product, the Canada sexually transmitted disease testing market is segmented into instruments and reagents & kits. Among these, the reagents & kits segment has the largest revenue share over the forecast period. The increasing prevalence of STDs in Canada and the growing use of these kits and reagents in diagnostic processes are responsible for the segment's expansion.

• In 2023, the point-of-care (POC) segment is witnessing significant growth over the forecast period.

Based on setting, the Canada sexually transmitted disease testing market is segmented into laboratory testing and point-of-care (POC). Among these, the point-of-care (POC) segment is witnessing significant growth over the forecast period. Point-of-care testing has grown in popularity due to its advantages over laboratory testing. Furthermore, it is anticipated that market participants' growing attention will boost segmental expansion as they introduce point-of-care testing kits for the detection of STDs.

• In 2023, the syphilis segment is witnessing significant growth over the forecast period.

Based on application, the Canada sexually transmitted disease testing market is segmented into chlamydia, syphilis, genital herpes, gonorrhea, human immunodeficiency virus, human papillomavirus (HPV), and others. Among these, the syphilis segment is witnessing significant growth over the forecast period. The greatest growth of the category is anticipated to come from a rising number of Canadians contracting syphilis throughout the projection period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Canada sexually transmitted disease testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• LifeLabs Medical Laboratory Services
• BC Centre for Disease Control (BCCDC)
• STI Technologies Limited
• BioSyent Inc
• Telemedicine Canada
• Dynacare
• BioReference Laboratories Canada
• Alberta Health Services
• Canadian Foundation for Infectious Diseases (CFID)
• Biosante

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at regional, and country levels from 2022 to 2033. Spherical Insights has segmented the Canada Sexually Transmitted Disease Testing Market based on the below-mentioned segments:

Canada Sexually Transmitted Disease Testing Market, By Product

• Instruments
• Reagents & Kits

Canada Sexually Transmitted Disease Testing Market, By Setting

• Laboratory Testing
• Point-of-Care (POC)

Canada Sexually Transmitted Disease Testing Market, By Application

• Chlamydia
• Syphilis
• Genital Herpes
• Gonorrhea
• Human Immunodeficiency Virus
• Human Papillomavirus (HPV)
• Others